These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


320 related items for PubMed ID: 11794865

  • 1. Hepatitis C treatment, HAART and side effects.
    TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
    [No Abstract] [Full Text] [Related]

  • 2. [HIV and hepatitis C coinfection].
    Stoehr A, Brinkmann K, Sabranski M.
    MMW Fortschr Med; 2008 Apr 28; 150 Spec No 1():54-5, 57. PubMed ID: 19024919
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Genotype 1 superresponder treat for only 24 weeks].
    MMW Fortschr Med; 2005 Dec 15; 147(51-52):69. PubMed ID: 16402717
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interferon for hepatitis C patients with psychiatric disorders.
    Rifai MA, Bozorg B, Rosenstein DL.
    Am J Psychiatry; 2004 Dec 15; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
    [No Abstract] [Full Text] [Related]

  • 7. "Hepatitis C (HCV) treatment is not a "one size fits all".
    Bukeirat FA, Bukeirat MM.
    W V Med J; 2012 Dec 15; 108(2):20, 22-4. PubMed ID: 22655431
    [Abstract] [Full Text] [Related]

  • 8. Anterior ischemic optic neuropathy in a patient with hepatitis C treated with interferon-alpha and ribavirin.
    Knyazer B, Lifshitz T, Marcus M, Kratz A, Zlotnik A, Levy J.
    Isr Med Assoc J; 2011 Apr 15; 13(4):251-3. PubMed ID: 21598818
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Peginterferon- and ribavirin-induced bipolar episode successfully treated with lamotrigine without discontinuation of antiviral therapy.
    Navinés R, Castellví P, Solà R, Martín-Santos R.
    Gen Hosp Psychiatry; 2008 Apr 15; 30(4):387-9. PubMed ID: 18585548
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Eliminating the gray zone. What can be done in normal ALT values?].
    MMW Fortschr Med; 2004 Apr 26; 146 Spec No 1():75. PubMed ID: 15373059
    [No Abstract] [Full Text] [Related]

  • 15. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
    Farshidi D, Chiu MW.
    J Am Acad Dermatol; 2010 Jan 26; 62(1):164-165. PubMed ID: 20082904
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Healing hepatitis C infections. Pegylated interferon alfa-2a opens new perspectives].
    MMW Fortschr Med; 2003 Jun 26; 145(26):52-3. PubMed ID: 12916339
    [No Abstract] [Full Text] [Related]

  • 20. A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis.
    Shimada M, Yoshida S, Kornek M, Kim SJ, Schuppan D.
    Liver Int; 2010 Nov 26; 30(10):1552-4. PubMed ID: 20557455
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.